Skip to main content

News

Icap, Reuters sell their stakes in Blackbird

UK inter-dealer broker Icap and information company Reuters have sold their minority stakes in Charlotte, North Carolina-based electronic inter-dealer broker Blackbird. The development effectively ends 18 months of bitter dispute between Icap and…

Bank of China International chooses Sophis

BOC International Financial Products, a division of Hong Kong-listed Bank of China International, has selected risk management software company Sophis to support the front, middle and back office of its new derivatives unit.

Banks go live on CLS

Continuous Linked Settlement (CLS) - the long-awaited industry initiative to cut settlement risk for foreign exchange - will go live today.

Derivatives volumes soar in US, says OCC

Notional derivatives volumes held by US commercial banks increased by $3.8 trillion in second-quarter 2002, to $50.1 trillion - the second highest amount ever recorded, the US Office of the Comptroller of the Currency (OCC) reported yesterday in its…

Chinese derivatives development appears far off

The timetable for the development of the Chinese regulated derivatives market, both domestically and for international investors, appears unclear, with the likelihood that foreign investors will not gain direct access to Chinese markets for several years…

SAP launches new Basel II functions for mySAP Banking

German software services provider SAP said it is providing new functions for its mySAP Banking package to help banks meet the requirements of the risk-based Basel II capital Accord and new international accounting standards in the European Union (EU).

Hedge funds targeted by Summit-CoVision alliance

Summit Systems, a New York-based trading, risk management and straight-through processing vendor, and CoVision Capital Group, an investment management firm, have partnered to provide an investment platform specifically geared towards hedge funds.

You need to sign in to use this feature. If you don’t have a Risk.net account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here